Founding Klaus Märtens was a doctor in the
German Army during
World War II. After he injured his ankle while skiing in 1945, he found that his standard-issue army
boots were too uncomfortable on his injured foot. While recuperating, he designed improvements to the boots, with soft
leather and air-padded soles made of tyres. When the war ended and Germans looted valuables from their own cities, Märtens purchased leather from a
shoemaker's shop. With that leather he made himself a pair of boots with air-cushioned soles. In 1947, Märtens did not have much success selling his shoes until he met up with an old
university friend Herbert Funck in
Munich. Funck was intrigued by the new shoe design, and the two went into business that year in
Seeshaupt, Germany, using discarded
rubber shaped by moulds. The comfortable soles were a big hit with housewives, with 80 percent of sales in the first decade to women over the age of 40.
Expansion in the United Kingdom Sales had grown so much by 1952 that they opened a factory in Munich. In 1959, the company had grown large enough that Märtens and Funck looked at marketing the footwear internationally. Almost immediately, British shoe manufacturer R. Griggs Group bought
patent rights to manufacture the shoes in the United Kingdom. The R. Griggs Group
anglicised the company name to
Dr. Martens. The heel was reshaped for a better fit and the trademark yellow stitching was added. The sole was formally
trademarked. The shoes' popularity among
politically right-wing skinheads led to the brand gaining an association with violence. , London In 1989, the Accent Group became the first manufacturer of Dr. Martens outside the UK, obtaining the rights to make them in
Dunedin, New Zealand, which they did for several years. The boots and shoes became popular in the 1990s as
grunge fashion arose. In late November 1994, a six-storey Dr. Martens
department store was opened in
Covent Garden in London which also sold food, belts, and watches. At this time the R. Griggs company employed 2,700 people, expected to earn annual revenue of £170 million, and could produce up to 10 million pairs of shoes per year.
Sponsorship The Dr. Martens company sponsored
Rushden & Diamonds F.C. from 1998 to 2005. Diamonds approached owner and local businessman
Max Griggs to request sponsorship from his company. A new main stand was built at
Nene Park in 2001, named the Airwair Stand. Dr. Martens were also the principal sponsors of
Premier League club,
West Ham United F.C. from 1998 to 2003, renaming the upgraded west stand 'The Dr Martens Stand'.
Trademark disputes In 1999, Dr. Martens fought lawsuits in US courts. The brand filed a number of lawsuits in 2016 based primarily on
trademark law.
Expansion , Vaughan, Ontario, Canada In the 2000s, Dr. Martens were sold exclusively under the AirWair name in dozens of different styles, including conventional black shoes, sandals and
steel-toed boots. AirWair International Ltd revenue fell from $412 million in 1999 to $127 million in 2006. In 2003 the Dr. Martens company came close to
bankruptcy. On 1 April that year, under pressure from declining sales, the company ceased making shoes in the UK, and moved all production to
China and
Thailand. Five factories and two shops were closed in the UK, and more than of the firm's employees lost their jobs. Following the closures, the R. Griggs company employed only 20 people in the UK, all in the firm's head office. Five million pairs of Dr. Martens were sold during 2003, half the 1990s level of sales. In 2004, a new range of Dr. Martens was launched in an attempt to appeal to a wider market, especially young people. The shoes and boots were intended to be more comfortable, and easier to break in, and included some new design elements. Sales of these shoes are low in comparison to those made in Asia, however; in 2010, the factory was producing about 50 pairs per day. Worldwide sales of Dr. Martens shoes grew strongly in the early 2010s, and in 2012 it was the eighth-fastest-growing British company. Over 100 million pairs of Dr. Martens shoes were sold from 1960 to 2010, and in 2010 the company offered 250 different models of footwear. and also launched a line of clothing during 2011.
Private equity investment The private equity company
Permira acquired R. Griggs Group Limited, the owner of the Dr. Martens brand, for £300 million in October 2013. For a time Dr. Martens footwear was sold under a "for life" scheme, under which it would repair or replace worn-out DM shoes forever for a price somewhat more than twice the normal price for a pair. This offer was available in 2016, but was withdrawn for new sales from May 2018. After Permira purchased Dr. Martens the former brand president of
Vans was hired as CEO.
Production issues In 2018, ten million pairs of Dr. Martens shoes were produced, only one percent in the UK. Annual revenue in 2019 was £454 million, six times more than in 2013. The most popular model remained the 1460 boots. Dr Martens' design studio is in
Camden Town, London. In 2019,
The Guardian reported concerns that the quality of Dr. Martens shoes had declined since either production was moved to Asia or Permira acquired the brand. Many of the newspaper's readers reported that recently produced Dr. Martens products did not last as long as older production. The company responded that there had been no change in the materials used or production processes since manufacturing was moved to Asia, and only 0.5% of its footwear was defective.
Listing on the London Stock Exchange Dr. Martens was listed on the London Stock Exchange at a value of £3.7 billion in January 2021. == Subcultural significance ==